11/15
03:26 pm
sxtp
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Low
Report
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
11/14
02:31 pm
sxtp
60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results
Low
Report
60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results
10/3
09:07 am
sxtp
60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch [Yahoo! Finance]
High
Report
60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch [Yahoo! Finance]
10/3
09:02 am
sxtp
60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch
Medium
Report
60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch
9/13
02:09 pm
sxtp
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Medium
Report
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
9/6
09:12 am
sxtp
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
Low
Report
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]
9/6
08:59 am
sxtp
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Low
Report
60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
9/4
08:00 am
sxtp
60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Low
Report
60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
11/14
03:38 pm
sxtp
Form SC 13G 60 DEGREES PHARMACEUTICA Filed by: ARMISTICE CAPITAL, LLC
Low
Report
Form SC 13G 60 DEGREES PHARMACEUTICA Filed by: ARMISTICE CAPITAL, LLC
11/14
01:45 pm
sxtp
Form 10-Q 60 DEGREES PHARMACEUTICA For: Sep 30
Low
Report
Form 10-Q 60 DEGREES PHARMACEUTICA For: Sep 30
11/13
04:01 pm
sxtp
Form SC 13G/A 60 DEGREES PHARMACEUTICA Filed by: Knight Therapeutics Inc
Medium
Report
Form SC 13G/A 60 DEGREES PHARMACEUTICA Filed by: Knight Therapeutics Inc
11/6
05:26 pm
sxtp
Form 8-K 60 DEGREES PHARMACEUTICA For: Nov 06
Medium
Report
Form 8-K 60 DEGREES PHARMACEUTICA For: Nov 06
10/15
03:47 pm
sxtp
Form DEF 14A 60 DEGREES PHARMACEUTICA For: Nov 06
Low
Report
Form DEF 14A 60 DEGREES PHARMACEUTICA For: Nov 06
10/8
08:18 am
sxtp
Form 8-K 60 DEGREES PHARMACEUTICA For: Oct 02
Medium
Report
Form 8-K 60 DEGREES PHARMACEUTICA For: Oct 02
10/2
10:57 am
sxtp
Form PRE 14A 60 DEGREES PHARMACEUTICA For: Oct 02
Medium
Report
Form PRE 14A 60 DEGREES PHARMACEUTICA For: Oct 02
10/1
06:04 am
sxtp
Form EFFECT 60 DEGREES PHARMACEUTICA
High
Report
Form EFFECT 60 DEGREES PHARMACEUTICA
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register